Long-term outcomes of mitral valve replacement in dialysis patients: evidence from a nationwide database

被引:0
作者
Yang, Kelvin J. [1 ]
Fu, Hsun-Yi [2 ]
Chang, Chia-Jui [3 ,4 ]
Wang, Ting-Chuan [5 ]
Wang, Chih-Hsien [1 ]
Chou, Nai-Kuan [1 ]
Wu, I-Hui [1 ]
Hsu, Ron-Bin [1 ]
Huang, Shu-Chien [1 ]
Yu, Hsi-Yu [1 ]
Chen, Yih-Sharng [1 ]
Chi, Nai-Hsin [1 ,6 ]
机构
[1] Natl Taiwan Univ Hosp, Dept Cardiovasc Surg, Taipei, Taiwan
[2] Natl Taiwan Univ Hosp, Dept Cardiovasc Surg, Hsin Chu Branch, Hsinchu, Taiwan
[3] Natl Taiwan Univ, Grad Inst Clin Pharm, Coll Med, Taipei, Taiwan
[4] Natl Taiwan Univ, Canc Ctr, Dept Pharm, Taipei, Taiwan
[5] Natl Taiwan Univ, Hlth Data Res Ctr, Taipei, Taiwan
[6] Natl Taiwan Univ Hosp, Dept Surg, 8 Chung Shan S Rd, Taipei, Taiwan
关键词
end-stage renal disease; hemodialysis; mitral valve; prosthetic valve; valve replacement; STAGE RENAL-DISEASE; AMERICAN-HEART-ASSOCIATION; TASK-FORCE; MANAGEMENT; GUIDELINES; SURVIVAL; KIDNEY;
D O I
10.1097/JS9.0000000000000684
中图分类号
R61 [外科手术学];
学科分类号
摘要
Background: To compare the late outcomes between mechanical and bioprostheses after isolated mitral valve replacement (MVR) in dialysis-dependent patients. Methods: A nationwide propensity-matched retrospective cohort study was conducted involving dialysis patients who underwent primary mitral replacement between 2001 and 2018. Ten-year postoperative outcomes were compared between mitral bioprosthesis and mechanical prosthesis using the Cox proportional hazard model and restricted mean survival time (RMST). Results: The all-cause mortality was 20.8 and 13.0 events per 100 person-years, with a 10-year RMST of 7.40 and 7.31 years for bioprosthesis and mechanical prosthesis, respectively. Major bleeding was the most common adverse event for both bioprosthesis and mechanical prosthesis, with an incidence rate of 19.5 and 19.1 events per 100 person-years, respectively. The incidence of valve reoperation was higher among those who received bioprosthesis (0.55 events per 100 person-years). After 1:1 matching, the all-cause mortality was 15.45 and 14.54 events per 100 person-years for bioprosthesis and mechanical prosthesis, respectively. The RMST at 10 years was comparable between the two groups after matching (5.10 years for bioprosthesis vs. 4.59 years for mechanical prosthesis), with an RMST difference of -0.03. Further, no difference was observed in the incidence of major adverse valve-related events between bioprosthesis and mechanical valves. However, bioprosthesis was associated with a higher incidence of mitral valve reoperation among all major adverse events (RMST difference -0.24 years, 95% CI -0.48 to -0.01, P=0.047). Conclusions: This study found no association between valve selection and long-term survival outcomes in dialysis patients after MVR. However, bioprosthetic valves may be associated with a slightly higher incidence of reoperation, while other valve-related adverse events, including major bleeding and stroke, were comparable between the two types of prostheses.
引用
收藏
页码:3778 / 3787
页数:10
相关论文
共 50 条
  • [31] Long-Term Outcomes of Bioprosthetic or Mechanical Valve Replacement in End-Stage Renal Disease: A Nationwide Population-Based Retrospective Study
    Li, Guan-Yi
    Chen, Yun-Yu
    Chung, Fa-Po
    Chien, Kuo-Liong
    Hsu, Chiao-Po
    Lin, Yenn-Jiang
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2021, 8
  • [32] Long-term results after concomitant mitral and aortic valve surgery: repair or replacement?
    Coutinho, Goncalo F.
    Martinez Cereijo, Jose M.
    Correia, Pedro M.
    Lopes, Catarina S.
    Reija Lopez, Laura
    Duran Munoz, Dario
    Antunes, Manuel J.
    EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 2018, 54 (06) : 1085 - 1092
  • [33] Intermediate-term outcomes of aortic valve replacement with bioprosthetic or mechanical valves in patients on hemodialysis
    Nakatsu, Taro
    Minakata, Kenji
    Tanaka, Shiro
    Minatoya, Kenji
    Nishizawa, Junichiro
    Ohno, Nobuhisa
    Esaki, Jiro
    Ueyama, Koji
    Koyama, Tadaaki
    Hanyu, Michiya
    Tamura, Nobushige
    Komiya, Tatsuhiko
    Saito, Yuhei
    Kanemitsu, Naoki
    Soga, Yoshiharu
    Shiraga, Kotaro
    Nakayama, Shogo
    Nonaka, Michihito
    Sakaguchi, Genichi
    Nishimura, Kazunobu
    Yamanaka, Kazuo
    JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2019, 157 (06) : 2177 - +
  • [34] Bioprosthetic mitral valve replacement in patients aged 65 years or younger: long-term outcomes with the Carpentier-Edwards PERIMOUNT pericardial valve
    Bourguignon, Thierry
    Espitalier, Fabien
    Pantaleon, Clemence
    Vermes, Emmanuelle
    El-Arid, Jean Marc
    Loardi, Claudia
    Karam, Elias
    Candolfi, Pascal
    Ivanes, Fabrice
    Aupart, Andmichel
    EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 2018, 54 (02) : 302 - 309
  • [35] Comparative analysis of structural valve deterioration and long-term clinical outcomes after bovine pericardial versus porcine bioprosthetic mitral valve replacement
    Kim, Woojung
    Hwang, Ho Young
    Kang, Yoonjin
    Kim, Ji Seong
    Sohn, Suk Ho
    Choi, Jae Woong
    Kim, Kyung Hwan
    JOURNAL OF THORACIC DISEASE, 2021, 13 (07) : 3969 - +
  • [36] Long-term outcomes of catheter ablation of atrial fibrillation post-cardiac valve replacement
    Zhao, Liang
    Xu, Kai
    Jiang, Weifeng
    Zhou, Li
    Wang, Yuanlong
    Zhang, Xiaodong
    Wu, Shaohui
    Zhang, Daoliang
    Liu, Xu
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2016, 225 : 82 - 86
  • [37] Long-Term Outcomes of Atrioventricular Valve Surgery in Patients with Functional Single Ventricle: Should We Avoid Valve Replacement?
    Lim, Jae Hong
    Kwak, Jae Gun
    Min, Jooncheol
    Cho, Sungkyu
    Kim, Woong-Han
    PEDIATRIC CARDIOLOGY, 2021, 42 (07) : 1546 - 1553
  • [38] RISK OF AND FATALITY FROM ACUTE PANCREATITIS IN LONG-TERM HEMODIALYSIS AND PERITONEAL DIALYSIS PATIENTS
    Wang, I-Kuan
    Lai, Shih-Wei
    Lai, Hsueh-Chou
    Lin, Cheng-Li
    Yen, Tzung-Hai
    Chou, Che-Yi
    Chang, Chiz-Tzung
    Huang, Chiu-Ching
    Sung, Fung-Chang
    PERITONEAL DIALYSIS INTERNATIONAL, 2018, 38 (01): : 30 - 36
  • [39] Comparing long-term outcomes of septal myectomy and mitral valve replacement in hypertrophic cardiomyopathy patients: A retrospective cohort study in Iran
    Ayati, Aryan
    Khoshfetrat, Mehran
    Davoodi, Saeed
    Ahmadi Tafti, Seyed Hossein
    Arefizadeh, Reza
    HEALTH SCIENCE REPORTS, 2024, 7 (04)
  • [40] Short- and long-term outcome after surgical aortic valve replacement in patients on dialysis
    Perrotta, Sossio
    Nielsen, Susanne J.
    Hansson, Emma C.
    Lepore, Vincenzo
    Martinsson, Andreas
    Jeppsson, Anders
    Lindgren, Martin
    JOURNAL OF THORACIC DISEASE, 2022, 14 (02) : 269 - +